In-Stent Restenosis: Chasing Our Tails in Search of a Solution
- PMID: 32043490
- PMCID: PMC7000883
- DOI: 10.1016/j.jacbts.2019.12.002
In-Stent Restenosis: Chasing Our Tails in Search of a Solution
Keywords: liposomes; percutaneous coronary intervention; restenosis; ultrasound.
Figures


Comment on
-
Stabilizing Peri-Stent Restenosis Using a Novel Therapeutic Carrier.JACC Basic Transl Sci. 2019 Nov 28;5(1):1-11. doi: 10.1016/j.jacbts.2019.09.005. eCollection 2020 Jan. JACC Basic Transl Sci. 2019. PMID: 32043017 Free PMC article.
References
-
- Otsuka F., Byrne R.A., Yahagi K. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36:2147–2159. - PubMed
-
- Marx N., Wohrle J., Nusser T. Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients. Circulation. 2005;112:2792–2798. - PubMed
-
- Hausleiter J., Kastrati A., Mehilli J. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation. 2004;110:790–795. - PubMed
-
- Joner M., Byrne R.A. The importance of preclinical research in contemporary interventional cardiology. EuroIntervention. 2010;6:19–23. - PubMed
Publication types
LinkOut - more resources
Full Text Sources